Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




'Flat-Line ECG' Indicates Poor Outcomes for Out-Of-Hospital Cardiac Arrest

By HospiMedica International staff writers
Posted on 10 Oct 2025

Asystole, often referred to as a “flat-line” ECG, represents the most severe form of cardiac arrest in which the heart ceases all electrical activity. More...

It is a global medical emergency with extremely poor survival rates, and outcomes remain dismal despite advances in emergency medicine. In many countries, emergency responders can terminate resuscitation efforts under specific conditions.

Little is known about the epidemiology of out-of-hospital cardiac arrest with asystole in countries where prehospital resuscitation is not withheld or terminated. For instance, in some regions, such as Japan, emergency medical services (EMS) must continue life support procedures, providing a unique opportunity to evaluate their real-world impact. Now, a large data study has revealed that 'flat-line ECG' indicates poor outcomes for out-of-hospital cardiac arrest.

Researchers from Hiroshima University (Hiroshima, Japan) conducted a large-scale study using national health data to assess whether pre-hospital life support interventions improve outcomes for patients experiencing asystole outside hospitals. The study, published in JAMA Network Open, analyzed detailed patient records and outcomes over a six-year period, offering one of the most comprehensive evaluations of emergency cardiac care in Japan.

The research included 60,349 adults who experienced out-of-hospital cardiac arrest between 2014 and 2020. Among them, 35,843 (≈59.4%) presented with asystole, and 93.9% received advanced life support (ALS) interventions such as airway management and intravenous epinephrine. Patients who received early defibrillation before emergency teams arrived or lacked ALS involvement were excluded to ensure uniformity of results.

The findings revealed that advanced airway management increased the odds of 30-day survival by 45%, while intravenous epinephrine improved it by 81%. However, neither intervention was associated with improved favorable neurological outcomes. Out of nearly 36,000 patients with asystole, only 497 survived beyond 30 days, and just 67 achieved a favorable neurological recovery. These data suggest that survival alone does not necessarily translate into meaningful recovery for most patients.

Further analysis showed that more than a third (35.5%) of these patients would have met the international criteria for termination of resuscitation, yet resuscitation continued under Japan’s emergency care system. Only 0.1% of these individuals demonstrated good neurological function at 30 days. These findings underscore the need to re-evaluate emergency response protocols and discuss the potential adoption of termination-of-resuscitation guidelines to better align resource use with patient outcomes.

Related Links:
Hiroshima University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.